A detailed history of Rathbones Group PLC transactions in Exscientia PLC stock. As of the latest transaction made, Rathbones Group PLC holds 11,070 shares of EXAI stock, worth $53,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,070
Previous 12,222 9.43%
Holding current value
$53,578
Previous $62,000 12.9%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.26 - $6.0 $4,907 - $6,912
-1,152 Reduced 9.43%
11,070 $54,000
Q2 2024

Aug 09, 2024

BUY
$3.99 - $6.04 $1,995 - $3,020
500 Added 4.27%
12,222 $62,000
Q1 2024

May 14, 2024

BUY
$5.3 - $7.51 $2,681 - $3,800
506 Added 4.51%
11,722 $67,000
Q4 2023

Feb 13, 2024

BUY
$4.35 - $6.88 $3,897 - $6,164
896 Added 8.68%
11,216 $71,000
Q3 2023

Nov 13, 2023

BUY
$4.52 - $8.9 $46,646 - $91,848
10,320 New
10,320 $46,000

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $593M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.